Axonics® Files for Premarket Approval with U.S. Food & Drug Administration for its Sacral Neuromodulation System by Seini Moimoi | Dec 4, 2018 | Portfolio News
Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting by Seini Moimoi | Dec 3, 2018 | Portfolio News
Aptinyx Reports Positive Data from Interim Analysis of Exploratory Study of NYX-2925 in Subjects with Fibromyalgia by Seini Moimoi | Dec 3, 2018 | Portfolio News
Inflazome Appoints Dr Thomas Jung as Chief Medical Officer by Seini Moimoi | Nov 29, 2018 | Portfolio News
